NURS 220: Anti-inflammatory RX Review

Inflammation Overview

  • Inflammation occurs with any type of cell injury, serving to destroy, dilute, or wall off (sequester) both the injurious agent and the injured tissue.

  • It is mediated by endogenous compounds, including:

    • Proteins of the complement system

    • Histamine

    • Serotonin

    • Bradykinin

    • Leukotrienes

    • Prostaglandins

Arachidonic Acid Pathway

  • Arachidonic acid is oxygenated and transformed into various products that mediate or modulate inflammatory reactions via two primary pathways:

    • Leukotriene pathway (Lipoxygenase):

      • Leads to vasoconstriction and increased vascular permeability, contributing to inflammation.

    • Prostaglandin pathway (Cyclooxygenase, COX-1 & COX-2):

      • COX-1: maintains gi mucosam as well as inflamatory repsonse

      • COX-2 Primary role is inflamation repsonse

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

  • Definition: A large and chemically diverse group of drugs.

  • Mechanisms of Action:

    • Inhibition of the leukotriene pathway, prostaglandin pathway, or both.

    • Blocking the chemical activity of the cyclooxygenase (COX) enzyme.

  • Types of NSAIDs (by COX Selectivity):

    • Non-selective COX Inhibitors: Inhibit both COX-1 and COX-2 enzymes. They offer anti-inflammatory, analgesic, and antipyretic effects but also carry GI and renal side effects due to COX-1 inhibition. Examples include Ibuprofen, Naproxen, and traditional aspirin doses.

    • COX-2 Selective Inhibitors: Primarily inhibit COX-2, minimizing GI side effects by largely sparing COX-1. While effective for inflammation and pain, they are associated with an increased risk of cardiovascular thrombotic events due to an imbalance between PGI2 TXA2. Celecoxib is a prime example.

  • Therapeutic Effects:

    • Analgesic (pain relief)

    • nti-inflammatory

    • Antipyretic (fever reduction)

    • Platelet inhibition

NSAID Side Effects and Underlying Mechanisms

  • NSAIDs exert side effects primarily through COX inhibition, impacting various physiological systems:

    • Gastrointestinal (GI) Effects (linked to COX-1 inhibition):

      • COX-1 is responsible for producing PGE2PGE_2 (prostaglandin E2) which promotes gastric protection by increasing mucus secretion, bicarbonate production, and mucosal blood flow.

      • Inhibition of COX-1 by NSAIDs reduces these protective factors, leading to:

        • Peptic ulcers

        • GI bleeding

    • Renal Effects (linked to COX-1 and COX-2 inhibition):

      • PGE<em>2PGE<em>2 and PGI</em>2PGI</em>2 (prostacyclin) cause afferent arteriolar vasodilation, maintaining glomerular filtration rate (GFR).

      • These prostaglandins also promote sodium and water excretion.

      • COX inhibition by NSAIDs leads to:

        • Sodium and water retention

        • Hypertension

        • Hemodynamic acute kidney injury (e.g., reductions in creatinine clearance, acute tubular necrosis).

    • Cardiovascular Effects (linked to COX-1 and COX-2 inhibition):

      • Vascular (COX-2: PGI2PGI_2) promotes vasodilation and inhibits platelet aggregation.

      • Platelet (COX-1: TXA2TXA_2 - thromboxane) promotes vasoconstriction and platelet aggregation.

      • Differential inhibition can lead to imbalances:

        • COX-2 selective inhibitors might reduce PGI<em>2PGI<em>2 without affecting TXA</em>2TXA</em>2, potentially increasing risk of thrombotic events.

        • COX-1 inhibition (like with aspirin) inhibits TXA2TXA_2, preventing platelet aggregation.

      • Overall, NSAID use (except aspirin) has a Black Box Warning for increased risk of adverse cardiovascular thrombotic events, including fatal myocardial infarction (MI) and stroke.

      • NSAIDs may counteract the cardioprotective effects of aspirin.

Chemical Categories of NSAIDs

  • Salicylates: Aspirin, Arthropan

  • Acetic acid derivatives: Indocin (Indomethacin), Voltaren (Diclofenac), Toradol (Ketorolac)

  • Cyclooxygenase-2 (COX-2) inhibitors: Celebrex (Celecoxib)

  • Propionic acid derivatives: Ibuprofen (Motrin, Advil), Naproxen (Aleve)

  • Enolic acid derivatives: Relafen (Nabumetone), Mobic (Meloxicam), Feldene (Piroxicam)

Specific NSAIDs and Related Information

Salicylates: Aspirin (ASA)

  • Most common salicylate.

  • Actions:

    • Inhibits synthesis of prostaglandin, reducing pain and fever.

    • Inhibitor of COX-1 receptors within platelets, inhibiting platelet aggregation (antithrombotic effect).

  • Pharmacokinetics:

    • Metabolized in the liver, excreted in the urine.

    • Peak effect in 5−305-30 minutes.

  • Formulations: Oral (PO), Topical, Per Rectal (PR) suppositories.

  • Dosing:

    • Maximum: 40004000 mg/day.

    • Pain/fever: 650650 mg every 4−64-6 hours.

    • Antithrombotic: Varies (e.g., 325325 mg PO chewed at the first sign of MI).

  • Antithrombotic Use:

    • Used in the treatment of MI and other thromboembolic disorders.

    • Shown to reduce cardiac death after MI.

    • Should be administered at the first sign of MI.

    • If not given pre-hospital, it's one of the first drugs in the ED if no contraindications.

  • Contraindications:

    • Known allergy.

    • Bleeding abnormalities.

    • Impaired renal or hepatic function.

    • Avoid use in children and teenagers due to the risk of Reye’s Syndrome.

Salicylate Toxicity (Salicism)

  • Symptoms:

    • Increased heart rate.

    • Tinnitus, hearing loss, dimness of vision.

    • Headache, dizziness, mental confusion, drowsiness.

    • Nausea, vomiting, diarrhea.

    • Sweating, thirst.

    • Hyperventilation.

    • Hypo- or hyperglycemia.

  • Reye's Syndrome:

    • A serious and potentially fatal condition characterized by encephalopathy and liver damage.

    • High risk with aspirin use in children and teens, especially if recovering from viral illnesses (e.g., flu, chickenpox).

Acetic Acid Derivatives

  • Indomethacin (Indocin):

    • Analgesic, anti-inflammatory, antirheumatic, and antipyretic properties.

    • Uses: Rheumatoid arthritis (RA), osteoarthritis (OA), acute bursitis or tendonitis, ankylosing spondylitis, acute gouty arthritis, patent ductus arteriosus (PDA), and treatment of preterm labor.

    • Available in oral, rectal, and intravenous forms.

  • Ketorolac (Toradol):

    • Possesses some anti-inflammatory activity.

    • Used primarily for its powerful analgesic effects, comparable to narcotic drugs like morphine.

    • Indication: Short-term use (up to 55 days) for moderate to severe acute pain.

    • Adverse effects: Renal impairment, edema, GI pain, dyspepsia, nausea.

COX-2 Inhibitors

  • Celecoxib (Celebrex):

    • Currently the first and only remaining COX-2 inhibitor.

    • Indications: OA, RA, acute pain symptoms, ankylosing spondylitis, and primary dysmenorrhea.

    • Adverse effects: Headache, sinus irritation, diarrhea, fatigue, dizziness, lower extremity edema, and hypertension.

    • Has little effect on platelet function.

    • Contraindication: Not to be used in patients with known sulfa allergy.

Propionic Acid Derivatives

  • Ibuprofen (Motrin, Advil):

    • Most commonly used NSAID.

    • Uses: Analgesic effects in the management of RA, OA, primary dysmenorrhea, gout, dental pain, musculoskeletal disorders, and antipyretic actions.

  • Naproxen (Aleve):

    • Second most commonly used NSAID.

    • Generally has a better adverse effect profile than ibuprofen.

    • Fewer drug interactions with ACE inhibitors (used for hypertension).

Enolic Acid Derivatives

  • Used to treat mild to moderate OA, RA, and gouty arthritis.

  • Examples: Piroxicam (Feldene), Meloxicam (Mobic), Nabumetone (Relafen).

  • Nabumetone is generally better tolerated gastrointestinally than some other NSAIDs.

General NSAID Contraindications and Black Box Warnings

  • Black Box Warning: All NSAIDs (except aspirin) carry a black box warning regarding an increased risk of adverse cardiovascular thrombotic events, including fatal MI and stroke.

    • NSAIDs may counteract the cardioprotective effects of aspirin.

  • Known drug allergy.

    • Patients with documented aspirin allergy must not receive NSAIDs.

  • Conditions that place the patient at risk for bleeding:

    • Vitamin K deficiency.

    • Peptic ulcer disease.

    • Liver dysfunction.

  • Pregnancy: Misoprostol (Cytotec), a synthetic prostaglandin used to reduce stomach ulcers caused by NSAIDs, is contraindicated in pregnancy as it may cause abortion, premature birth, or birth defects.

Other NSAID Adverse Effects (General)

  • GI: Dyspepsia, heartburn, epigastric distress, nausea, GI bleeding, mucosal lesions (erosions or ulcerations).

    • Management: Misoprostol (Cytotec) may be prescribed to high-risk patients to reduce these dangerous effects.

  • Renal: Reductions in creatinine clearance, acute tubular necrosis with renal failure.

  • Cardiovascular: Noncardiogenic pulmonary edema (swelling).

  • Other Systems: Altered hemostasis, hepatotoxicity, skin eruption, sensitivity reaction, tinnitus, hearing loss.

Nursing Implications for NSAIDs

  • Do not give salicylates to children and teenagers due to the risk of Reye’s syndrome.

  • NSAIDs generally cause GI distress; they are often better tolerated if taken with food, milk, or an antacid to avoid irritation.

  • Inform patients that therapeutic effects may not be seen for 33 to 44 weeks.

  • Educate patients about adverse effects and instruct them to notify prescribers if effects become severe or if bleeding or GI pain occurs.

  • Advise patients to watch closely for any unusual bleeding, such as in the stool.

  • Enteric-coated tablets should not be crushed or chewed.

  • Monitor for therapeutic effects, which vary depending on the condition being treated (e.g., decrease in swelling, pain, stiffness, and tenderness of a joint or muscle area).

NSAID Interactions

  • Serious interactions can occur when given with:

    • Anticoagulants (increased bleeding risk).

    • Aspirin (NSAIDs may reduce cardioprotective effects of aspirin).

    • Corticosteroids and other ulcerogenic drugs (increased GI ulceration/bleeding risk).

    • Protein-bound drugs (competition for binding sites, altered drug levels).

    • Diuretics and ACE inhibitors (reduced effectiveness of these drugs, increased risk of renal toxicity).

Norco vs. Vicodin and Acetaminophen

  • Both Norco and Vicodin are combination drugs containing hydrocodone and acetaminophen (APAP).

  • Vicodin: 55mg hydrocodone / 500500mg APAP.

  • Norco: 1010mg hydrocodone / 325325mg APAP.

  • Norco has a higher proportion of hydrocodone to acetaminophen than Vicodin.

  • Acetaminophen:

    • Does not reduce inflammation.

    • Has no effect on platelets.

    • Provides only analgesic (pain relief) effects.

    • Mechanism of action is unknown; metabolized in the liver.